Bolton Securities’s Regencell Bioscience RGC Stock Holding History
Bought
Maintained
Sold
Other funds holding RGC
Bolton Securities's RGC Position: Q1 2026 in Review
Bolton Securities sold out of Regencell Bioscience (RGC) in Q1 2026, closing a stake of 27,000 shares — an estimated $567K sold.
Bolton Securities first reported a position in RGC in Q3 2025 and held it in 2 quarters. The position peaked at $567K in Q4 2025. 33 funds tracked by Wall St. Rank hold RGC as of Q1 2026.
- Bolton Securities reported no remaining Regencell Bioscience position as of Q1 2026 after selling out during the quarter.
- Bolton Securities sold 27,000 Regencell Bioscience shares in Q1 2026, an estimated $567K.
- Bolton Securities first reported a position in Regencell Bioscience in Q3 2025 and held it in 2 quarters.
- Bolton Securities's Regencell Bioscience position peaked at $567K in Q4 2025.
- 33 funds tracked by Wall St. Rank held Regencell Bioscience as of Q1 2026.
Based on Bolton Securities's 13F filing for Q1 2026, filed 12 Nov 2026.